BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9580709)

  • 1. New positive/negative selectable markers for mammalian cells on the basis of Blasticidin deaminase-thymidine kinase fusions.
    Karreman C
    Nucleic Acids Res; 1998 May; 26(10):2508-10. PubMed ID: 9580709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new set of positive/negative selectable markers for mammalian cells.
    Karreman C
    Gene; 1998 Sep; 218(1-2):57-61. PubMed ID: 9751802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning of the blasticidin S deaminase gene (BSD) from Aspergillus terreus and its use as a selectable marker for Schizosaccharomyces pombe and Pyricularia oryzae.
    Kimura M; Kamakura T; Tao QZ; Kaneko I; Yamaguchi I
    Mol Gen Genet; 1994 Jan; 242(2):121-9. PubMed ID: 8159161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of replacement vectors for efficient gene targeting.
    Horie K; Nishiguchi S; Maeda S; Shimada K
    J Biochem; 1994 Mar; 115(3):477-85. PubMed ID: 8056760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified blasticidin S resistance gene (bsrm) as a selectable marker for construction of retroviral vectors.
    Freitas AC; Bento FM; Ramesh N; Osborne WR; Han SW
    J Biotechnol; 2002 Apr; 95(1):57-62. PubMed ID: 11879712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi: use of herpes simplex virus-thymidine kinase as a negative selectable marker.
    Buckner FS; Wilson AJ; Van Voorhis WC
    Exp Parasitol; 1997 Jul; 86(3):171-80. PubMed ID: 9225767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New selectable markers and single crossover integration for the highly versatile Plasmodium knowlesi transfection system.
    Wel Av; Kocken CH; Pronk TC; Franke-Fayard B; Thomas AW
    Mol Biochem Parasitol; 2004 Mar; 134(1):97-104. PubMed ID: 14747147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient expression of drug-selectable genes in retroviral vectors under control of an internal ribosome entry site.
    Sugimoto Y; Aksentijevich I; Gottesman MM; Pastan I
    Biotechnology (N Y); 1994 Jul; 12(7):694-8. PubMed ID: 7764914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
    Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
    Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer.
    Candotti F; Agbaria R; Mullen CA; Touraine R; Balzarini J; Johns DG; Blaese RM
    Cancer Gene Ther; 2000 Apr; 7(4):574-80. PubMed ID: 10811475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of fusion genes carrying drug resistance, green fluorescent protein, and herpes simplex virus thymidine kinase genes in a single cistron.
    Oh SC; Nam SY; Kwon HC; Kim CM; Seo JS; Seong RH; Jang YJ; Chung YH; Chung HY
    Mol Cells; 2001 Apr; 11(2):192-7. PubMed ID: 11355700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative selection of herpes simplex virus thymidine kinase in Toxoplasma gondii.
    Fox BA; Belperron AA; Bzik DJ
    Mol Biochem Parasitol; 2001 Aug; 116(1):85-8. PubMed ID: 11463470
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
    Guan J; Ma L; Wei L
    Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide sequence of the bsr gene and N-terminal amino acid sequence of blasticidin S deaminase from blasticidin S resistant Escherichia coli TK121.
    Kobayashi K; Kamakura T; Tanaka T; Yamaguchi I; Endo T
    Agric Biol Chem; 1991 Dec; 55(12):3155-7. PubMed ID: 1368770
    [No Abstract]   [Full Text] [Related]  

  • 15. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity.
    Rogulski KR; Kim JH; Kim SH; Freytag SO
    Hum Gene Ther; 1997 Jan; 8(1):73-85. PubMed ID: 8989997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus thymidine kinase-green fluorescent protein fusion gene: new tool for gene transfer studies and gene therapy.
    Loimas S; Wahlfors J; Jänne J
    Biotechniques; 1998 Apr; 24(4):614-8. PubMed ID: 9564534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells.
    Shewach DS; Zerbe LK; Hughes TL; Roessler BJ; Breakefield XO; Davidson BL
    Cancer Gene Ther; 1994 Jun; 1(2):107-12. PubMed ID: 7621241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
    Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
    Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene.
    Su H; Chang JC; Xu SM; Kan YW
    Hum Gene Ther; 1996 Mar; 7(4):463-70. PubMed ID: 8800740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo drug-selectable markers in gene therapy.
    Sugimoto Y; Tsuruo T
    Leukemia; 1997 Apr; 11 Suppl 3():552-6. PubMed ID: 9209454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.